Record Storage. As consideration for the fees owing to PCAS under clause 6, PCAS shall retain the products produced in the context of the Tasks and the related data (raw data, components, products produced in bulk, packaged batches, reference substances, stabilised substances, correspondence, technical documents and all other documentation concerning the Tasks), in accordance with GMP Chapter 19/19.8 and 19.9, [***] from the date of expiry or termination of the corresponding Work Order. At the end of this period, PCAS shall immediately inform ▇▇▇▇▇▇ and ▇▇▇▇▇▇ shall decide whether the said data should be returned, destroyed or retained for a longer period. PCAS must not destroy any data without ▇▇▇▇▇▇’s prior consent.
Appears in 2 contracts
Sources: Clinical Batch Development and Production Agreement (Abivax S.A.), Clinical Batch Development and Production Agreement (Abivax S.A.)